Discovery Pipeline
  • aldosterone synthase inhibitor

    Aldosterone synthase inhibitor is a highly anticipated drug in cardio-metabolic indication. Future drug will selectively inhibit synthesis of aldosterone .

    read more
  • anti-TB drug

    Wу are targeting a mycobacterial cytochromes P450, responsible for cell wall formation and depression of local immune response in human., for treatment of resistant (MDR, XDR) forms of tuberculosis. 

    read more
  • pipeline potential

    Separate progect serving to improve our technological platform, combined with pipeline extension and scientific collaborations activities

    read more
News and Events
01 November 2019
Crystera attends BIO-Europe 2019 (Hamburg, Germany) with oral presentation.
Crystera is selected to present at BIO-Europe 2019 in the Next Generation track.
22 October 2019
Crystera is a winner of Patents Power competition by Bayer AG
Crystera takes a 1st place in Patents Power competition, organised by Bayer AG.
03 June 2019
2019 BIO International Convention in Philadelphia, PA
Target Medicals is participating in largest biotech business partnering event of 2019
All news and events